These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26264705)

  • 1. Bifunctional siRNA containing immunostimulatory motif enhances protection against pandemic H1N1 virus infection.
    Joshi G; Dash PK; Agarwal A; Sharma S; Parida M
    Curr Gene Ther; 2015; 15(5):492-502. PubMed ID: 26264705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
    Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
    Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.
    Liang W; Chow MY; Lau PN; Zhou QT; Kwok PC; Leung GP; Mason AJ; Chan HK; Poon LL; Lam JK
    Mol Pharm; 2015 Mar; 12(3):910-21. PubMed ID: 25599953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective siRNAs inhibit the replication of novel influenza A (H1N1) virus.
    Zhiqiang W; Yaowu Y; Fan Y; Jian Y; Yongfeng H; Lina Z; Jianwei W; Qi J
    Antiviral Res; 2010 Mar; 85(3):559-61. PubMed ID: 20060420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine enkephalin inhibits influenza A virus infection through upregulating antiviral state in RAW264.7 cells.
    Tian J; Qu N; Jiao X; Wang X; Geng J; Griffin N; Shan F
    Int Immunopharmacol; 2020 Jan; 78():106032. PubMed ID: 31835089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
    Haasbach E; Droebner K; Vogel AB; Planz O
    J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery-mediated control of RNA immunostimulation.
    Nguyen DN; Chen SC; Lu J; Goldberg M; Kim P; Sprague A; Novobrantseva T; Sherman J; Shulga-Morskaya S; de Fougerolles A; Chen J; Langer R; Anderson DG
    Mol Ther; 2009 Sep; 17(9):1555-62. PubMed ID: 19584813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism.
    Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y
    Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection.
    Timin AS; Muslimov AR; Petrova AV; Lepik KV; Okilova MV; Vasin AV; Afanasyev BV; Sukhorukov GB
    Sci Rep; 2017 Mar; 7(1):102. PubMed ID: 28273907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.
    Heer AK; Shamshiev A; Donda A; Uematsu S; Akira S; Kopf M; Marsland BJ
    J Immunol; 2007 Feb; 178(4):2182-91. PubMed ID: 17277123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of West Nile virus Replication by Bifunctional siRNA Targeting the NS2A and NS5 Conserved Region.
    Karothia D; Dash PK; Parida M; Bhagyawant S; Kumar JS
    Curr Gene Ther; 2018; 18(3):180-190. PubMed ID: 29874999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo.
    Zhang Y; Yao J; Qi X; Liu X; Lu X; Feng G
    Antivir Ther; 2017; 22(7):599-611. PubMed ID: 28272019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2009 influenza pandemic: promising lessons for antiviral therapy for future outbreaks.
    Bavagnoli L; Maga G
    Curr Med Chem; 2011; 18(35):5466-75. PubMed ID: 22087838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation.
    Robbins M; Judge A; Ambegia E; Choi C; Yaworski E; Palmer L; McClintock K; MacLachlan I
    Hum Gene Ther; 2008 Oct; 19(10):991-9. PubMed ID: 18713023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
    Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.